期刊文献+

孟鲁司特钠治疗儿童呼吸道合胞病毒毛细支气管炎的临床评价 被引量:14

Effect of montelukast on clinical symptoms and prognosis of RSV in children with bronchiolitis
原文传递
导出
摘要 目的评价孟鲁司特钠在呼吸道合胞病毒(RSV)感染的儿童毛细支气管炎治疗中的应用价值。方法 120 例确诊RSV 感染性毛细支气管炎的患儿随机分为2 组,对照组和治疗组各60 例。对照组采用常规疗法,治疗组在对照组基础上加用孟鲁司特钠5 mg/次、口服1 次/d,比较治疗7 d 后两组的疗效及预后。结果治疗组患儿的咳嗽消失时间、喘憋消失时间、呼吸困难消失时间、部湿罗音消失时间、住院时间均显著的低于对照组(P<0.01)。治疗第3、7 天两组患儿的尿白三烯E4(LTE4)、血清半胱氨酸白三烯(CysLTS)、血氧饱和度(TcSaO2)均较治疗前显著好转(P<0.05),且治疗组优于对照组(P<0.05)。治疗第7 天治疗组患儿的临床有效率为95%,显著高于对照组的83.33%(P<0.05);治疗组的复发率为3.33%,显著低于对照组的13.33%(P<0.05)。结论孟鲁司特钠结合常规疗法治疗RSV 毛细支气管炎具有缩短治疗时间、尽快缓解临床症状,改善LTE4、CysLTS 炎症因子的作用,从而有效提高临床疗效。 Objective To evaluate the application value of montelukast sodium in the treatment of bronchiolitis infection induced by respiratory syncytial virus (RSV). Methods The confirmed RSV infection bronchiolitis children (120 cases) were randomly divided into control (n = 60) and treatment (n = 60) groups. The patients in the control group were given conventional therapy, while the patients in the treatment group were administered with montelukast sodium, po 5 mg/time, 1 time/d, after 5 d the treatment effects of two groups were compared. Results The disappeared time of cough, wheezing disappearance time, breathing difficulties disappearance time and lung wet rales disappearance time, hospitalization time in treatment group were significantly lower than those of normal group (P<0.01) in children. LTE4, serum CysLTS, and TcSaO2 were significantly improved in days 3 and 7 in two groups after treatment, compared with those before treatment (P<0.05), and the treatment group was significantly better than the conventional group (P<0.05). The clinical effective rate of treatment group was 95%, significantly higher than that of the conventional group(83.33%, P<0.05), and the recurrence rate was 3.33% in the treatment group was significantly lower than that in the conventional group(13.33%, P<0.05). Conclusion Montelukast sodium combined with conventional therapy in the treatment of RSV bronchiolitis has shorter treatment time, relieves the clinical symptoms as soon as possible, and improves LTE4, CysLTS role of cytokines, which can effectively improve the clinical efficacy.
作者 邓宇红 李莉
出处 《药物评价研究》 CAS 2015年第6期664-667,共4页 Drug Evaluation Research
关键词 呼吸机 辅助治疗 小儿重症毛细支气管炎 临床疗效 Ventilator adjuvant therapy children with severe bronchiolitis clinical effect
  • 相关文献

参考文献12

二级参考文献101

  • 1沈晓明,王卫平.儿科学[M].第7版.北京:人民卫生出版社,2008:38.
  • 2胡亚美,江载芳,诸福棠.实用儿科学[M].第7版.北京:人民卫生出版社,2006:821-825.
  • 3Jaffar Z,Sivakunu T,Roberts K.CD4+CD25+T cells regulateairway eosinophilic inflammation by modulating the Th2cell phenotype[J].J Immunol,2004,172(6):3842-3849.
  • 4Scherf W,Burdach S,Hansen G.Reduced expression oftransforming growth factor beta 1 exacerbates pathology inan experimental asthma model[J].Eur J Immunol,2005,35(1):198-206.
  • 5Bettelli E,Carrier Y,Gao W,et al.Reciprocal develop-mental pathways for the generation of pathogenic effectorTH17 and regulatory T cells[J].Nature,2006,441(7090):235-238.
  • 6Lee JH,Yu HH,Wang LC,et al.The levels of CD4+CD25+regulatory T cells in paediatric patients with allergicrhinitis and bronchial asthma[J].Clin Exp Immunol,2007,148(1):53-63.
  • 7Piippo-Savolainen E,Remes S,Kannisto S,et al.Asthmaand lung function 20 years after wheezing in infancy:results from a prospective follow-up study[J].Arch PediatrAdolesc Med,2004,158(11):1070-1076.
  • 8Sigurs N.A cohort of children hospitalised with acute RSVbronchiolitis:impact on later respiratory disease[J].Pae-diatr Respir Rev,2002,3(3):177-183.
  • 9Pala P,Bjarnason R,Sigurbergsson F,et al.EnhancedIL-4 responses in children with a history of respiratorysyncytial virus bronchiolitis in infancy[J].Eur Respir J,2002,20(2):376-382.
  • 10Mailaparambil B,Grychtol R,Heinzmann A.Respiratorysyncytial virus bronchiolitis and asthma-insights fromrecent studies and implications for therapy[J].InflammAllergy Drug Targets,2009,8(3):202-207.

共引文献225

同被引文献125

引证文献14

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部